Based at the UW School of Pharmacy, the UW–Madison Transdisciplinary Center for Research in Psychoactive Substances brings together leading scientists on the forefront of psychedelic research

University of Wisconsin–Madison School of Pharmacy Professor Paul Hutson serves as the founding director of the UW Transdisciplinary Center for Research in Psychoactive Substances
The University of Wisconsin–Madison is launching a new research center to coordinate ongoing research and education in psychedelic compounds, as evidence grows for their utility in treating substance abuse and psychiatric disorders, such as major depression and post-traumatic stress disorder (PTSD).

Housed within the UW–Madison School of Pharmacy, the Transdisciplinary Center for Research in Psychoactive Substances will conduct scholarly research into the science, history, and cultural impact of psychedelic agents, in addition to studying the potential for therapeutic use of psychoactive substances. This center will expand the scope and reach of the psychedelic research enterprise at UW–Madison to build on clinical studies that have been active on campus since 2014.

“From cannabis to psilocybin (magic mushrooms) and MDMA (ecstasy), psychoactive agents are the new frontier for potential new therapies and medications,” says Paul Hutson, founding center director and UW–Madison School of Pharmacy professor.